One Medical and Ascension Texas to Collaborate – Patch.com

One Medical is bringing its modernized, membership-based primary care model to Austin, and will partner with Ascension Texas to facilitate more seamless access and coordinated care across primary care and specialty care services.

One Medical's consumer-driven primary care platform combines seamless digital health and inviting in-office care convenient to where people work, shop, live and click. One Medical plans to launch in Austin with new medical office locations and its digital health services over the next 12 months, and will clinically and digitally integrate with Ascension Texas providers and sites of care in the community. Through this partnership, the two organizations aim to achieve greater care coordination between primary and specialty care settings, advance an exceptional experience for consumers and employers, and reduce administrative burdens and costs. Austin will be One Medical's 13th metropolitan market, following its anticipated entry into Atlanta, Georgia, Portland, Oregon, and Orange County, California in 2020.

"We greatly look forward to expanding to Austin in collaboration with Ascension Texas. Together, we will deliver streamlined access and a heightened experience across primary and specialty care settings, furthering our vision to delight our members with better health, better care, and lower costs," said John Singerling, Chief Network Officer of One Medical."

"As Ascension Texas primary care providers continue to serve the rapidly growing needs of the expanding Austin market, both in person and through virtual care, we look forward to welcoming One Medical providers to further care for the community," said Samson Jesudass, MD, Chief Clinical Officer, Ascension Texas. "Through this collaboration, our specialists will work with primary care providers to offer seamless specialty care and services to those we together are privileged to serve."

View post:

One Medical and Ascension Texas to Collaborate - Patch.com

Related Posts

Comments are closed.